[Prognostic value of the Charlson index in mortality in patients with pulmonary embolism associated with cancer versus non-tumour pulmonary embolism].
Autor: | Fernández Bermejo LA; Servicio de Medicina Interna, Hospital de la Fuenfría, Cercedilla, Madrid, España. Electronic address: larafernandezber@gmail.com., Gutiérrez Ortega C; Servicio de Medicina Preventiva, Hospital Central de la Defensa, Madrid, España., Jareño Esteban JJ; Servicio de Neumología, Hospital Central de la Defensa, Madrid, España. |
---|---|
Jazyk: | English; Spanish; Castilian |
Zdroj: | Medicina clinica [Med Clin (Barc)] 2022 Mar 11; Vol. 158 (5), pp. 201-205. Date of Electronic Publication: 2021 Apr 06. |
DOI: | 10.1016/j.medcli.2021.02.007 |
Abstrakt: | Introduction: The aim of this study is to analyse comorbidity, survival, and mortality from pulmonary embolism (PE) in people with cancer and without cancer. And to determine whether the Charlson Comorbidity Index (CCI) predicts mortality in the short and long term in this population. Methods: A retrospective observational study on survival in patients hospitalized in the Hospital Central de la Defensa from 1-01-2009 to 15-03-2018, stratifying into tumour PE group (EPT) and non-tumour PE group (EPnT), all of whom were classified according to age adjusted CCI. Results: A total of 368 patients were diagnosed with PE, 108 with associated cancer. The mean CCI in the EPT group was 7.2 and 4.5 in the EPnT group. Patients with PE and CCI>5 were 10.7 times more likely to die (95%CI 1.5-77.6) compared to CCI 0 (P=.019). The CCI of patients with EPT was 2.6 points higher (95%CI 1.9-33) than EPnT patients (P<.001). Cancer patients were 1.9 times more likely to die (95%CI 1.23-2.8) and had higher mortality at 30 days and at one year after the event, with a median survival of 8.98 years and 3.4 years, respectively (P<.001). Conclusions: The CCI in EPT is an independent risk factor related to mortality. The CCI can predict higher mortality in the short and long term in patients with PE. (Copyright © 2021 Elsevier España, S.L.U. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |